A detailed history of Advisory Alpha, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Advisory Alpha, LLC holds 2,642 shares of DXCM stock, worth $230,091. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,642
Holding current value
$230,091
% of portfolio
0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
$65.68 - $81.01 $173,526 - $214,028
2,642 New
2,642 $205,000
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $234 - $313
-3 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$95.51 - $112.95 $286 - $338
3 New
3 $394,000
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $188 - $316
-3 Closed
0 $0
Q1 2020

Apr 29, 2020

SELL
$47.79 - $75.63 $143 - $226
-3 Reduced 50.0%
3 $966,000
Q3 2019

Nov 13, 2019

BUY
$35.53 - $43.8 $213 - $262
6 New
6 $0
Q2 2019

Aug 16, 2019

SELL
$27.84 - $38.92 $167 - $233
-6 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$28.07 - $38.18 $168 - $229
6 New
6 $0

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Advisory Alpha, LLC Portfolio

Follow Advisory Alpha, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.